Aquilo Capital Management as of March 31, 2021
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 17 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Unit Put Option (SPY) | 21.5 | $119M | 300k | 396.33 | |
| Spdr S&p Biotech Etf Tr Unit Put Option (XBI) | 12.3 | $68M | 500k | 135.65 | |
| Spero Therapeutics (SPRO) | 10.2 | $56M | 3.8M | 14.72 | |
| Dicerna Pharmaceuticals | 7.9 | $44M | 1.7M | 25.57 | |
| Blueprint Medicines (BPMC) | 7.4 | $41M | 423k | 97.23 | |
| Ngm Biopharmaceuticals (NGM) | 5.9 | $33M | 1.1M | 29.07 | |
| Harpoon Therapeutics | 5.9 | $33M | 1.6M | 20.92 | |
| Uniqure Nv SHS (QURE) | 5.8 | $32M | 955k | 33.69 | |
| Magenta Therapeutics | 5.4 | $30M | 2.5M | 11.84 | |
| Arrowhead Pharmaceuticals (ARWR) | 4.9 | $27M | 408k | 66.31 | |
| Regenxbio Inc equity us cm (RGNX) | 3.4 | $19M | 559k | 34.11 | |
| 4d Molecular Therapeutics In (FDMT) | 2.4 | $13M | 301k | 43.38 | |
| Amryt Pharma Sponsored Ads | 2.0 | $11M | 800k | 13.93 | |
| Pieris Pharmaceuticals (PIRS) | 1.7 | $9.4M | 3.7M | 2.57 | |
| Galapagos Nv Spon Adr (GLPG) | 1.6 | $9.0M | 117k | 77.09 | |
| Argenx Se Sponsored Adr (ARGX) | 1.1 | $5.8M | 21k | 275.38 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.7 | $3.9M | 120k | 32.83 |
